MoneyWorks4Me

Ipca Laboratories informs about board meeting

21 Jan 2019 Evaluate

Ipca Laboratories has informed that the meeting of the Board of Directors of the Company is scheduled on 12/02/2019, to consider and take on record the Unaudited Financial Results for the 3rd quarter and nine months ended 31st December, 2018 of the financial year 2018-19.

The above information is a part of company’s filings submitted to BSE.

Ipca Laboratories Share Price

1733.65 -62.95 (-3.50%)
14-Aug-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1924.90
Dr. Reddys Labs. 1202.00
Cipla 1450.00
Lupin 2235.00
Zydus Lifesciences 1140.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: